Aquinox Pharma (AQXP) Misses Q2 EPS by 8c

Aquinox Pharma (NASDAQ: AQXP) reported Q2 EPS of ($0.59), $0.08 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $229 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Aquinox Pharma (AQXP) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c